November 30th 2012
Our colleague Dr. Henrike Brundiek has been awarded with the H. P. Kaufmann prize for her scientific work on the modification of lipases for increased selectivity towards trans-fatty acids.
November 12th 2012
Enzymicals AG gains access to the strain collection of technically useful microorganisms from the University of Greifswald. The collection currently contains about 6500 strains which are ready to use for biotransformation screenings at the company.
June 18th 2012
Braun Beteiligungs GmbH (BBG) has acquired a stake in Enzymicals AG to facilitate a stronger collaboration between Enzymicals AG, Herbrand PharmaChemicals GmbH and BRAIN AG.
April 5th 2012
Enzymicals will be present at the ACHEMA (June 18th-22nd in Frankfurt/M., Germany) in hall 9.2, booth C62. More attended conferences and trade fairs can be found in our dates section.
February 28th 2012
Enzymicals AG forged links in Philadelphia within a marketing aid program of the German Federal Ministry of Economics.
January 17th 2012
Enzymicals AG and Herbrand PharmaChemicals GmbH cooperate for biotechnological production of pharmaceuticals and intermediates.
June 21st 2011
Enzymicals AG and Lonza AG sign license agreement for the global use of (R)-selective transaminases in laboratory scale in Lonza patented processes.
June 1st 2011
White meets blue. Enzymicals AG and the Institute of Marine Biotechnology e.V. are going to cooperate in the areas of white and blue biotechnology.
May 23th 2011
Enzymicals now offers (R)-selective amine transaminases and more Baeyer-Villiger-monooxygenases in the updated enzyme catalog.
Additionally, we now offer screening kits for each enzyme class.
August 8th 2011
Enzymicals will be present at the Biotechnica (October 11th-13th in Hanover, Germany) in hall 9, stand E40. We will also give a presentation within the "Forum Industrielle Biotechnologie".
Moreover, we will attend CPhI Worldwide (October 25th-27th in Frankfurt/M., Germany) where we will be available for talks.
April 4th 2011
Due to company growth Enzymicals moved into new premises, expanding the lab space to 145 m2 and improving efficiency.
October 4th 2010
Enzymicals AG acquires proprietary rights on pig liver esterases (PLE) from Evonik AG.
July 12th 2010
BRAIN AG acquires share in chemical and biocatalyst specialist Enzymicals AG.
August 27th 2009
Enzymicals AG is founded.